Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Obstructive jaundice in prostate neoplasm. Case report].

C Whittle1, G Salgado, G Schiappacasse

  • 1Servicio de Radiología, Hospital San Juan de Dios, Facultad de Medicina Occidente, Universidad de Chile, Santiago de Chile. cwhittle@alemana.cl

Revista Medica De Chile
|June 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Improving cosmological reach of a gravitational wave observatory using Deep Loop Shaping.

Science (New York, N.Y.)·2025
Same author

Characterization of the epidemiologic, pathologic, radiologic, and management profile of patients with gastrointestinal stromal tumors (GISTs): A 5-year Chilean experience.

Revista de gastroenterologia de Mexico (English)·2025
Same author

Squamous Cell Carcinoma Developed in a Trichilemmal Cyst, an Incidental Finding.

Actas dermo-sifiliograficas·2024
Same author

Squeezing the quantum noise of a gravitational-wave detector below the standard quantum limit.

Science (New York, N.Y.)·2024
Same journal

[Health Education for Informed Autonomy: When to Begin?]

Revista medica de Chile·2026
Same journal

[Open Atrial Transcatheter Mitral Valve Replacement for Mitral Annular Calcification: First Case Report in Chile].

Revista medica de Chile·2026
Same journal

[From Opinion to Structure: The Role of Different Types of Systematic Reviews Within the Evidence Synthesis Ecosystem].

Revista medica de Chile·2026
Same journal

[Neuropsychiatric Effects of Creatine: What Does the Preclinical and Clinical Evidence Conclude?]

Revista medica de Chile·2026
Same journal

[Ethical Issues in Early Serological Diagnosis of Alzheimer's Disease].

Revista medica de Chile·2026
Same journal

[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 1].

Revista medica de Chile·2026
See all related articles

A 58-year-old male with advanced prostate cancer experienced jaundice due to metastatic disease. Treatment with orchiectomy and hormone therapy led to symptom resolution and sustained well-being for three years.

Area of Science:

  • Oncology
  • Urology

Background:

  • Advanced prostate cancer can present with obstructive jaundice due to metastatic spread.
  • Prostate-specific antigen (PSA) is a key biomarker for prostate cancer detection and monitoring.

Observation:

  • A 58-year-old male presented with malaise, weight loss, and jaundice.
  • Abdominal ultrasound revealed lymphadenopathy in the hepatic hilum and pancreas.
  • Fine needle aspiration confirmed undifferentiated carcinoma in lymph nodes.

Findings:

  • Elevated prostate-specific antigen (>100 ng/ml) and high-grade prostate carcinoma confirmed on biopsy.
  • Treatment involved orchiectomy and flutamide hormone therapy.
  • Successful resolution of jaundice and sustained patient well-being for 3 years.

Related Experiment Videos

Implications:

  • Orchiectomy combined with hormone therapy is an effective treatment for advanced prostate cancer presenting with obstructive jaundice.
  • This case highlights the importance of considering metastatic prostate cancer in the differential diagnosis of obstructive jaundice in elderly males.
  • Long-term hormone therapy can achieve durable remission and improve quality of life in patients with metastatic prostate cancer.